Furthermore, through its target gene, BTG3 (BTG anti-proliferation factor 3), and activation of autophagy-regulating MAPK signaling, its overexpression inhibits autophagy and promotes the malignant phenotype of nasopharyngeal cancer cells [28]. Here, BTG3 is linked to nasopharyngeal carcinoma.